MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
R3 Stem Cell, LLC (R3), a leader in regenerative therapy practices, issued a formal response to a letter it received from the FDA that raised concerns over alleged unapproved stem cell products to treat a variety of diseases and conditions as well as potential safety
R3 Stem Cell, LLC (R3), a leader in regenerative therapy practices, issued a formal response to a letter it received from the FDA that raised concerns over alleged unapproved stem cell products to treat a variety of diseases and conditions as well as potential safety
It’s not uncommon for new medical procedures and therapies to encounter resistance when they first emerge in the social sphere. Some initial skepticism is good. It helps us, as a society, proceed with caution to ensure safety. Luckily, we also have safeguards, strict regulations, and
When you hear amniotic fluid, there is a good chance that you immediately think of a pregnant person. However, there is a rapidly advancing field of medicine that also uses amniotic fluid, and it is known as regenerative medicine. Regenerative medicine is focused on repairing
It seems as though every day, a new study is published highlighting the benefits of regenerative procedures with amniotic and umbilical cord stem cells. To date, those have been small studies, but larger ones are occurring. Why Amniotic and Umbilical Cord Stem Cells May Be
With a constant flux of new and upcoming remedies and procedures arising in modern day medicine, it is no wonder that PRP Therapy and Regenerative Therapies are easily confused. Both of these therapies serve a wide range of people focus on healing in two completely
As far as the practice of medicine goes, stem cell research is incredibly new. In the early 1980s scientists discovered how to derive stem cells from mouse embryos. That discovery led to the ability to derive stem cells from human embryos, in 1998. A few
Regenerative medicine has been increasingly topical in recent years, mainly due to the increased occurrence of high-profile athletes using it to facilitate injury repair and get back in the game relatively quickly. Regenerative medicine covers a wide range of procedures and studies that center around
There have been a lot of conflicting stories about the use of stem cells in regenerative therapy in recent years. The truth has become shrouded in sensationalism and misinformation. This article addresses some of the major questions about stem cell therapy in order to clear
Hi, it’s Dr. David Greene, Founder and CEO of R3 Stem Cell, the nation’s leader in Regenerative Medicine Therapies. Today’s topic is the five main differences between bone marrow and umbilical stem cell therapy. Now, umbilical, I’m going to refer to more as perinatal, and
